#314 ‒ Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards | David Allison, Ph.D.

This podcast episode tackles the multifaceted challenges surrounding obesity research and public health initiatives, led by David Allison, who argues for a critical reevaluation of current approaches, advocating for a paradigm shift that accommodates both revolutionary treatment options like GLP-1 agonists and rigorous scientific investigation to address the environmental and ethical complexities of obesity management, ultimately urging the need for trustworthy research to guide effective solutions.